We estimate Q1 sales of SEK8,905m, organic growth of c1% YOY and adj. EBITA of SEK1,638m (4% below consensus). We expect a neutral outlook from management with regards to Q2, and have lowered our 2025–2027e adj. EBITA by c8% on average (mainly due to FX but also reduced demand estimates). We reiterate our HOLD but have lowered our target price to SEK390 (435) on updated valuation and estimates.
Our recent field trip to India (visiting Volvo, Epiroc, Trelleborg, Autoliv and others) alongside our analysis suggests the country is set to take centre stage as a global manufacturing hub over the coming decade, shifting from being the sixth- to the third-largest end-market for the Swedish Industrial sector. India’s strong economic growth trajectory and favourable demographics mean the companies: 1) see double-digit growth as sustainable; 2) are pursuing manufacturing capacity expansions; and ...
A solid Q4 included adj. EBITA c6% above consensus and our estimate. We are now more positive on short-term organic growth prospects and margins in Industrial Solutions and Medical Solutions. We have raised our 2025–2026e adj. EBITA by c3% on average, and our target price to SEK435 (425); however, with the stock looking fairly valued, we reiterate our HOLD.
We estimate Q4 sales of SEK8,628m, organic growth of c-1% YOY and adj. EBITA of SEK1,498m (2% above consensus). We expect a neutral outlook from management going into 2025, and have increased our 2024–2026e adj. EBIT by c2% on average (mainly due to FX). We reiterate our HOLD, but have raised our target price to SEK425 (400) on updated valuation and estimates. Trelleborg’s valuation premium relative to its Swedish Capital Goods peer group has increased recently, in our view leaving limited furth...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.